Abbildung von: The Yale Pharyngeal Residue Severity Rating Scale - Springer

The Yale Pharyngeal Residue Severity Rating Scale

Springer (Verlag)
Erschienen am 22. April 2016
XVII, 95 Seiten
E-Book
PDF mit Wasserzeichen-DRM
978-3-319-29899-3 (ISBN)
74,89 €inkl. 7% MwSt.
Systemvoraussetzungen
für PDF mit Wasserzeichen-DRM
E-Book Einzellizenz
Als Download verfügbar
This text is a reliable, validated, anatomically defined, and image-based tool to determine residue location and severity when performing fiberoptic endoscopic evaluation of swallowing (FEES). Based upon research by Drs. Leder and Neubauer, an easily interpreted, readily learned, and hierarchically organized pharyngeal residue severity rating scale was developed for speech-language pathologists, otolaryngologists, and other health care professionals who perform and interpret FEES. The Yale Pharyngeal Residue Severity Rating Scale works equally well for any swallow of interest, whether it is the first, subsequent clearing, or last swallow. The endoscopist simply has to match their chosen swallow with its scale mate.
The Yale Pharyngeal Residue Severity Rating Scale can be used for both clinical advantages and research opportunities. Clinically, clinicians can now accurately classify vallecula and pyriform sinus residue severity as none, trace, mild, moderate, or severe for diagnostic purposes, determination of functional therapeutic change, and precise dissemination of shared information. Research uses include tracking outcomes for clinical trials, investigating various swallowing interventions, demonstrating efficacy of specific interventions to reduce pharyngeal residue, determining morbidity and mortality associated with pharyngeal residue in different patient populations, and improving the training and accuracy of FEES interpretation by students and clinicians. The Yale Pharyngeal Residue Severity Rating Scale is an important addition to the deglutologist's tool box.
Produkt-Info
eBook
Auflage
1st ed. 2016
Sprache
Englisch
Verlagsort
Cham
Schweiz
Verlagsgruppe
Springer International Publishing
Illustrationen
10 s/w Tabellen, 7 s/w Abbildungen, 9 farbige Abbildungen
XVII, 95 p. 16 illus., 9 illus. in color.
Dateigröße
Dateigröße: 2,90 MB
Schlagworte
ISBN-13
978-3-319-29899-3 (9783319298993)
Schweitzer Klassifikation
Thema Klassifikation
DNB DDC Sachgruppen
Dewey Decimal Classfication (DDC)
BIC 2 Klassifikation
BISAC Klassifikation
Warengruppensystematik 2.0
Steven B. Leder, Ph.D., CCC-SLP, Professor, Dept. of Surgery, Section of Otolaryngology, received his doctorate in speech-language pathology from the University of Connecticut in 1983. Dr. Leder was the research speech-language pathologist on the first single-channel cochlear implant project in the nation at the Veterans Affairs Medical Center, West Haven, CT from 1983-1986. He then worked at Yale-New Haven Hospital before accepting an academic appointment at Yale University School of Medicine in 1991. Dr. Leder has published extensively in the areas of dysphagia diagnostics and rehabilitation, head and neck cancer, voice restoration with tracheoesophageal prostheses, and patients with tracheotomy and ventilator dependency.
Paul Neubauer, MD, is a physician in the Department of Surgery (Otolaryngology) at Yale School of Medicine.

Uniquely designed for oncologists and general practitioners, this book offers clinicians comprehensive guidelines when dealing with women at high risk for breast cancer. Written by experts in the field on the cutting edge of this research, the following questions will be answered for the reader by the end of the book: Who is at elevated risk for breast cancer, who should be genetically screened, when and how often should we obtain imaging and what type of imaging is adequate, what medications are available for prevention, when is surgical intervention appropriate, and finally, what lifestyle changes should be implemented to prevent this disease?

With one in eight women likely to contract breast cancer in her lifetime, the significance of identifying and managing the high-risk patient is evident. Breakthroughs in the identification of genes associated with breast carcinoma, particularly BRCA1 and 2, as well as other risk factors, influence not only how patients are screened, but also how they are treated. Breast Cancer Prevention provides a guided approach to prevention of breast cancer in women at elevated risk for this malignancy.

Dateiformat: PDF
Kopierschutz: Wasserzeichen-DRM (Digital Rights Management)

Systemvoraussetzungen:

  • Computer (Windows; MacOS X; Linux): Verwenden Sie zum Lesen die kostenlose Software Adobe Reader, Adobe Digital Editions oder einen anderen PDF-Viewer Ihrer Wahl (siehe E-Book Hilfe).
  • Tablet/Smartphone (Android; iOS): Installieren Sie bereits vor dem Download die kostenlose App Adobe Digital Editions oder die App PocketBook (siehe E-Book Hilfe).
  • E-Book-Reader: Bookeen, Kobo, Pocketbook, Sony, Tolino u.v.a.m. (nur bedingt: Kindle)

Das Dateiformat PDF zeigt auf jeder Hardware eine Buchseite stets identisch an. Daher ist eine PDF auch für ein komplexes Layout geeignet, wie es bei Lehr- und Fachbüchern verwendet wird (Bilder, Tabellen, Spalten, Fußnoten). Bei kleinen Displays von E-Readern oder Smartphones sind PDF leider eher nervig, weil zu viel Scrollen notwendig ist. Mit Wasserzeichen-DRM wird hier ein „weicher” Kopierschutz verwendet. Daher ist technisch zwar alles möglich – sogar eine unzulässige Weitergabe. Aber an sichtbaren und unsichtbaren Stellen wird der Käufer des E-Books als Wasserzeichen hinterlegt, sodass im Falle eines Missbrauchs die Spur zurückverfolgt werden kann.

Weitere Informationen finden Sie in unserer  E-Book Hilfe.